FDA inspection
Novo Nordisk Production Ireland Limited: FDA inspection ending Oct 28, 2022
FDA inspection 1202701 · Voluntary Action Indicated (VAI) · Athlone
Key facts
| Inspection ID | 1202701 |
|---|---|
| Firm | Novo Nordisk Production Ireland Limited |
| FEI number | 3002806873 |
| Address | Monksland Industrial Estate |
| City | Athlone |
| Country | Ireland |
| Fiscal year | 2023 |
| Inspection end date | Oct 28, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data